bioAffinity Technologies Announces 1-for-15 Reverse Stock Split

What Happened

• bioAffinity Technologies, Inc. filed a Form 8-K reporting an amendment to its certificate of incorporation to implement a board-approved one-for-fifteen (1-for-15) reverse stock split of its common stock. The reverse split was authorized by shareholders at the April 30, 2026 annual meeting (the amendment allowed a 1-for-2 to 1-for-250 range) and the Board selected the 1-for-15 ratio.
• The Certificate of Amendment was filed with the Delaware Secretary of State on August 20, 2026 and the Reverse Stock Split becomes effective at 4:01 p.m. Eastern Time on August 21, 2026. The company’s common stock will trade on a split-adjusted basis on the Nasdaq when the market opens on August 24, 2026. A press release dated August 20, 2026 was furnished as Exhibit 99.1.

Key Details

• Reverse split ratio: 1-for-15 (every 15 pre-split shares will combine into 1 post-split share).
• Effective time/date: 4:01 p.m. ET on August 21, 2026; Nasdaq trading adjusted August 24, 2026.
• Corporate mechanics: No change to total authorized shares or par value; proportionate adjustments to outstanding stock options, restricted stock units, warrants and plan share reserves; fractional shares to be paid in cash.
• Ticker and CUSIP: Common stock continues trading under symbol “BIAF”; new CUSIP assigned (09076W406).

Why It Matters

• The reverse split reduces the number of outstanding shares and increases the per-share price mathematically, which the company says is intended to help regain compliance with Nasdaq’s minimum bid price requirement.
• Ownership percentages of shareholders remain the same (other than cash-outs for fractional shares); option and warrant holders will see proportional adjustments to exercise prices and share counts.
• Investors should note the new CUSIP and that trading will resume on a split-adjusted basis on Aug 24, 2026; holders in brokerage or book-entry form do not need to take action, while record holders will receive instructions from the transfer agent.